Advanced search
Start date
Betweenand


Estradiol Protects Female ApoE KO Mice against Western-Diet-Induced Non-Alcoholic Steatohepatitis

Full text
Author(s):
Araujo, Layanne C. C. ; Cruz, Alessandra G. ; Camargo, Felipe N. ; Sucupira, Felipe G. ; Moreira, Gabriela V. ; Matos, Sandro L. ; Amaral, Andressa G. ; Murata, Gilson Masahiro ; Carvalho, Carla R. O. ; Camporez, Joao Paulo
Total Authors: 10
Document type: Journal article
Source: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; v. 24, n. 12, p. 15-pg., 2023-06-01.
Abstract

The prevalence of non-alcoholic fatty liver disease (NAFLD) and its severe form, non-alcoholic steatohepatitis (NASH), is higher in men than in women of reproductive age, and postmenopausal women are especially susceptible to developing the disease. Aim: we evaluated if female apolipoprotein E (ApoE) KO mice were protected against Western-diet (WD)-induced NASH. Methods: Female ovariectomized (OVX) ApoE KO mice or sham-operated (SHAM) mice were fed either a WD or a regular chow (RC) for 7 weeks. Additionally, OVX mice fed a WD were treated with either estradiol (OVX + E2) or vehicle (OVX). Results: Whole-body fat, plasma glucose, and plasma insulin were increased and associated with increased glucose intolerance in OVX mice fed a WD (OVX + WD). Plasma and hepatic triglycerides, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) hepatic enzymes were also increased in the plasma of OVX + WD group, which was associated with hepatic fibrosis and inflammation. Estradiol replacement in OVX mice reduced body weight, body fat, glycemia, and plasma insulin associated with reduced glucose intolerance. Treatment also reduced hepatic triglycerides, ALT, AST, hepatic fibrosis, and inflammation in OVX mice. Conclusions: These data support the hypothesis that estradiol protects OVX ApoE KO mice from NASH and glucose intolerance. (AU)

FAPESP's process: 19/18965-9 - Effect of increased estrogen receptor alpha expression by adeno-associated virus on hepatic metabolism
Grantee:Felipe Nunes de Camargo
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 18/04956-5 - Impact of the estrogen receptor alpha on Non-Alcoholic Fatty Liver Disease and energetic metabolism of the liver
Grantee:João Paulo Gabriel Camporez
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 20/09094-1 - Impact of galectin-3 inhibition on hepatic insulin resistance and energy metabolism in Non-Alcoholic Steato-Hepatitis
Grantee:Layanne Cabral da Cunha Araujo
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 21/02638-9 - Impact of estrogen receptor alpha on non-alcoholic fatty liver disease and liver energy metabolism
Grantee:Felipe Garcia da Silva Sucupira
Support Opportunities: Scholarships in Brazil - Master